Literature DB >> 1831301

Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre.

D C Weir1, P Sherwood Burge.   

Abstract

A study was carried out to examine the independence from starting prebronchodilator FEV1 of four indices commonly used to express airflow (FEV1) reversibility in response to bronchodilators. In 121 patients with chronic airflow obstruction with a mean prebronchodilator FEV1 of 1.81 (43.9% of predicted values) the change in FEV1 expressed as a percentage of the patient's predicted FEV1 was the least dependent on starting FEV1. Reversibility, expressed as a percentage of the prebronchodilator value or as a percentage of the maximal possible increase (predicted minus starting FEV1) was correlated with starting FEV1.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1831301      PMCID： PMC1020913          DOI： 10.1136/thx.46.1.43

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  3 in total

1.  Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction.

Authors:  D S Postma; K de Vries; G H Koëter; H J Sluiter
Journal:  Am Rev Respir Dis       Date:  1986-08

2.  Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.

Authors:  D C Weir; R I Gove; A S Robertson; P S Burge
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

3.  Prognosis in chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; E C Wright; J E Hodgkin
Journal:  Am Rev Respir Dis       Date:  1986-01
  3 in total
  9 in total

Review 1.  Occupational lung disease. 8. The diagnosis of occupational asthma from serial measurements of lung function at and away from work.

Authors:  P Bright; P S Burge
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

2.  Diagnostic accuracy of the bronchodilator response in children.

Authors:  Sze Man Tse; Diane R Gold; Joanne E Sordillo; Elaine B Hoffman; Matthew W Gillman; Sheryl L Rifas-Shiman; Anne L Fuhlbrigge; Kelan G Tantisira; Scott T Weiss; Augusto A Litonjua
Journal:  J Allergy Clin Immunol       Date:  2013-05-14       Impact factor: 10.793

3.  Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD Study Group.

Authors:  H A Kerstjens; P L Brand; P H Quanjer; B A van der Bruggen-Bogaarts; G H Koëter; D S Postma
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

Review 4.  Risks versus benefits of inhaled beta 2-agonists in the management of asthma.

Authors:  B J Lipworth
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

5.  Bronchial responsiveness and acute bronchodilator response in chronic obstructive pulmonary disease and diffuse panbronchiolitis.

Authors:  H Koyama; K Nishimura; T Mio; A Ikeda; N Sugiura; T Izumi
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

6.  Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction.

Authors:  F W Dekker; A C Schrier; P J Sterk; J H Dijkman
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139

7.  Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.

Authors:  P L Brand; P H Quanjer; D S Postma; H A Kerstjens; G H Koëter; P N Dekhuijzen; H J Sluiter
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

8.  Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.

Authors:  D C Weir; P S Burge
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

9.  Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.

Authors:  Daphne C Richter; James R Joubert; Haylene Nell; Mace M Schuurmans; Elvis M Irusen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.